⌘K

Login Start Free

Home/Filings/4/0001144204-18-033530

4//SEC Filing

NASH DAVID 4

Accession 0001144204-18-033530

CIK 0001023024other

View on SEC.gov Company Profile

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 4:02 PM ET

Size

7.1 KB

Accession

0001144204-18-033530

Insider Transaction Report

Form 4

Period: 2018-06-06

ANI PHARMACEUTICALS INCANIP

Director

Transactions

Award
Stock Options
2018-06-06+2,225→ 2,225 total
Exercise: $65.86Exp: 2028-06-05→ Common Stock (2,225 underlying)
Award
Common Stock
2018-06-06+1,800→ 1,800 total

Footnotes (1)

[F1]The restricted stock and stock options are subject to vesting, and 50% of the restricted stock and stock options vest on May 17, 2019, and the remaining 50% of the restricted stock and stock options vest on May 17, 2020.

Documents

1 file

4
tv496175_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

ANI PHARMACEUTICALS INC

CIK 0001023024

Entity typeother

Related Parties

1

filerCIK 0001251968

Filing Metadata

Form type: 4
Filed: Jun 7, 8:00 PM ET
Accepted: Jun 8, 4:02 PM ET
Size: 7.1 KB

View on SEC.gov